MedTrace Logo

The Study of Percutaneous Mechanical Thrombectomy Treating Acute Deep Vein Thrombosis of Lower Extremities

NCT05356767 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2022-05-11

No results posted yet for this study

Summary

This study is a prospective, multicenter, real world, observational study intended to understand tmechanical thrombectomy in the treatment of acute deep venous thrombosis of lower extremities, It is estimated that 600 patients with DVT were enrolled in the group at 24 centers nationwide from May 2022 to May2024. we can obtain data on the incidence of sequelae of deep venous thrombosis after PMT, and analyze the factors that may affect the efficacy of PMT.

Conditions

  • Pharmacomechanical Thrombolysis
  • Deep Vein Thrombosis

Interventions

PROCEDURE

Pharmacomechanical thrombolysis

Pharmacomechanical thrombolysis

Sponsors & Collaborators

  • Chengdu University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Meng Ye, doctor · Study Principal Investigator RenJi Hospital

  • Ziheng Wu, doctor · Study Principal Investigator Zhejiang University

  • Lianrui Guo, doctor · Study Principal Investigator Xuanwu Hospital, Beijing

  • Xin Fang, doctor · Study Principal Investigator Hangzhou first people's Hospital of Medical College of Zhejiang University

  • Hongfei Sang, doctor · Study Principal Investigator Second Affiliated Hospital of Suzhou University

  • Qiang Li, doctor · Study Principal Investigator Qingdao Haici Hospital affiliated to Qingdao University

  • Zibo Feng, doctor · Study Principal Investigator Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

  • Zhenyu Shi, doctor · Shanghai Zhongshan Hospital

  • Weihao Shi, doctor · Huashan Hospital

  • Wensheng Lou, doctor · The First Affiliated Hospital With Affiliated Nanjing Medical University

  • Hui Zhao, doctor · Affiliated Hospital of Nantong University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-04-01
Completion
2026-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05356767 on ClinicalTrials.gov